Literature DB >> 27325459

Interleukin 15: A key cytokine for immunotherapy.

Manoj Patidar1, Naveen Yadav2, Sarat K Dalai3.   

Abstract

Interleukin (IL)-15, a member of the immunoregulatory cytokines family, is a pluripotent molecule with therapeutic potential. It is predominantly expressed by the myeloid cells, as well as other cell types. IL-15 serves multiple functions including dictating T cell response, regulating tissue repair and B cell homing, modulating inflammation, and activating NK cells. Among cytokines, IL-15 is unique because of its wide expression, tightly regulated secretion, trans-presentation, and therapeutic potential. IL-15 has been investigated for its therapeutic potential for the induction and maintenance of T cell responses. In addition, IL-15 can be targeted by antibody- or mutant IL-15 therapy to reduce inflammation. Its multifaceted biological applications are crucial in immunotherapy. In this article, we review the functions, expression, and regulation of IL-15 for designing an improved IL-15-based therapy targeting the IL-15 signaling pathway.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Interleukin-15; JAK/STAT; mTOR

Mesh:

Substances:

Year:  2016        PMID: 27325459     DOI: 10.1016/j.cytogfr.2016.06.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  44 in total

1.  Human endometrial stromal cell decidualization requires transcriptional reprogramming by PLZF.

Authors:  Maria M Szwarc; Lan Hai; William E Gibbons; Mary C Peavey; Lisa D White; Qianxing Mo; David M Lonard; Ramakrishna Kommagani; Rainer B Lanz; Francesco J DeMayo; John P Lydon
Journal:  Biol Reprod       Date:  2018-01-01       Impact factor: 4.285

2.  Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15.

Authors:  Stephen R Morris; Bonnie Chen; Joseph C Mudd; Soumya Panigrahi; Carey L Shive; Scott F Sieg; Cheryl M Cameron; David A Zidar; Nicholas T Funderburg; Souheil-Antoine Younes; Benigno Rodriguez; Sara Gianella; Michael M Lederman; Michael L Freeman
Journal:  JCI Insight       Date:  2020-06-04

Review 3.  The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

Authors:  Domenico Galati; Serena Zanotta; Marialuisa Bocchino; Rosaria De Filippi; Antonio Pinto
Journal:  Cancer Immunol Immunother       Date:  2021-01-01       Impact factor: 6.968

4.  Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events.

Authors:  Michelle de Campos Soriani Azevedo; Heloisa Marques; Larissa Sarri Binelli; Mariana Silva Vieira Malange; Amanda Carreira Devides; Eliane Aparecida Silva; Luciana Raquel Vincenzi Fachin; Cassio Cesar Ghidella; Cleverson Teixeira Soares; Gustavo Pompermaier Garlet; Patrícia Sammarco Rosa; Andrea de Farias Fernandes Belone; Ana Paula Favaro Trombone
Journal:  Med Microbiol Immunol       Date:  2017-09-05       Impact factor: 3.402

Review 5.  The role of interleukins and the widely studied TNF-α in non-Hodgkin's lymphoma.

Authors:  Kyle P D'mello; Lei Zhao; Erin C Kaser; Ziwen Zhu; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Med Oncol       Date:  2021-04-09       Impact factor: 3.064

6.  Mass Cytometry Analytical Approaches Reveal Cytokine-Induced Changes in Natural Killer Cells.

Authors:  Elena Vendrame; Julia Fukuyama; Dara M Strauss-Albee; Susan Holmes; Catherine A Blish
Journal:  Cytometry B Clin Cytom       Date:  2017-01       Impact factor: 3.058

7.  Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice.

Authors:  Tiange Chen; Yajing Zhang; Zhao Wang; Jie Yang; Mingming Li; Kunlun Wang; Min Cui; Zhen F Fu; Ling Zhao; Ming Zhou
Journal:  Virol Sin       Date:  2017-08-29       Impact factor: 4.327

8.  A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.

Authors:  Wenjun Mou; Jianxin He; Xi Chen; Hui Zhang; Xiaoya Ren; Xunyao Wu; Xin Ni; Baoping Xu; Jingang Gui
Journal:  Immunogenetics       Date:  2016-08-26       Impact factor: 2.846

Review 9.  Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.

Authors:  Joachim Koch; Michael Tesar
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

10.  Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect.

Authors:  Martin Felices; Alexander J Lenvik; Ron McElmurry; Sami Chu; Peter Hinderlie; Laura Bendzick; Melissa A Geller; Jakub Tolar; Bruce R Blazar; Jeffrey S Miller
Journal:  JCI Insight       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.